A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Non-alcoholic Fatty Liver Disease

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

GSK Investigational Site, Arcadia, California, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Elias Tarakji)
GSK Investigational Site, Covina, California, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Masoud Azizad)
GSK Investigational Site, Los Angeles, California, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Joseph Lamb)
GSK Investigational Site, Santa Maria, California, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Keval Shah)
GSK Investigational Site, Van Nuys, California, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Robert Jenders)
GSK Investigational Site, Boynton Beach, Florida, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Aaron Cohen)
GSK Investigational Site, Cape Coral, Florida, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Paige Kreegel)
GSK Investigational Site, Hialeah, Florida, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Isaac Bassan, MD)
GSK Investigational Site, Hialeah, Florida, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Jorge Diaz)
GSK Investigational Site, Inverness, Florida, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Paul Hellstern Jr.)
GSK Investigational Site, Jacksonville, Florida, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Jeffry Jacqmein)
GSK Investigational Site, Kissimmee, Florida, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Luis Alvarado)
GSK Investigational Site, Lakeland, Florida, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (James Andersen)
GSK Investigational Site, Maitland, Florida, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Eva Maria Heurich)
GSK Investigational Site, Miami, Florida, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Yaneicy Gonzalez Rojas)
GSK Investigational Site, Miami, Florida, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Carlos Ramos)
GSK Investigational Site, Miami, Florida, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (JORGE AMAYA)
GSK Investigational Site, Miami, Florida, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Lazaro M Garcia)
GSK Investigational Site, Miami, Florida, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Franciso Bautista)
GSK Investigational Site, Miami Lakes, Florida, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Miguel Aponte)
GSK Investigational Site, Ocala, Florida, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Robert Barish)
GSK Investigational Site, Palmetto Bay, Florida, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Karen Figueredo Reyes)
GSK Investigational Site, Topeka, Kansas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Shekhar Challa)
GSK Investigational Site, Springfield, Missouri, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Dmitry Shuster)
GSK Investigational Site, St Louis, Missouri, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Fred Williams)
GSK Investigational Site, East Syracuse, New York, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Barbara Connor)
GSK Investigational Site, New York, New York, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Samar Hameed)
GSK Investigational Site, New York, New York, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Eli Shalenberg)
GSK Investigational Site, Morehead City, North Carolina, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Kathryn Lucas)
GSK Investigational Site, Akron, Ohio, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Ganesh Veerappan)
GSK Investigational Site, Springboro, Ohio, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Anjali Morey)
GSK Investigational Site, Chattanooga, Tennessee, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Chirag Patel)
GSK Investigational Site, Austin, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Nomita Kim)
GSK Investigational Site, Austin, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Michael Patrick Zimmerman)
GSK Investigational Site, Bellaire, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Everald Manning)
GSK Investigational Site, Brownsville, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Christopher Romero)
GSK Investigational Site, Dallas, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Valentine Ebuh)
GSK Investigational Site, DeSoto, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Haresh Boghara)
GSK Investigational Site, Richmond, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Brian Chou)
GSK Investigational Site, San Antonio, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Eric Lawitz)
GSK Investigational Site, San Antonio, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Emanuel DeNoia)
GSK Investigational Site, Seabrook, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Joe Pouzar)
GSK Investigational Site, Sugar Land, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Harish Thakkar)
GSK Investigational Site, Tomball, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Muhammad Irfan)
GSK Investigational Site, Waco, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Gregg Lucksinger)
GSK Investigational Site, Waco, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Hanumantha Ancha)
GSK Investigational Site, West Jordan, Utah, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Barbara Rizzardi)
GSK Investigational Site, Manassas, Virginia, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Nabil Andrawis)
GSK Investigational Site, Seattle, Washington, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Kris Kowdley)

מובילי המחקר

GSK Clinical Trials
Study Director
GlaxoSmithKline

צפייה במקור ב־ClinicalTrials.gov

ניסויים דומים

ניסויים נוספים שמגייסים כעת ועשויים להיות רלוונטיים לפי מצב רפואי, טיפול, שלב או מיקום

Quantifying Hepatic Mitochondrial Fluxes in Humans

Non-Alcoholic Fatty Liver Disease · Type 2 Diabetes · Mitochondrial Metabolism Disorders

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE4

San Antonio, United States · San Antonio, United States

Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLD

Non-Alcoholic Fatty Liver Disease

חו"ל (דורש נסיעה)מגייס משתתפים

Québec, Canada

A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat

Fatty Liver Disease

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

Montreal, Canada

NAC- NAFLD And Cushing

Cushing Syndrome · Fatty Liver Disease

חו"ל (דורש נסיעה)מגייס משתתפים

Angers, France · Bordeaux, France